Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Consolidated Net Income (2016 - 2021)

Historic Consolidated Net Income for Neurocrine Biosciences (NBIX) over the last 12 years, with Q3 2021 value amounting to $22.5 million.

  • Neurocrine Biosciences' Consolidated Net Income rose 13906.25% to $22.5 million in Q3 2021 from the same period last year, while for Dec 2021 it was $96.9 million, marking a year-over-year increase of 6313.13%. This contributed to the annual value of $37.0 million for FY2019, which is 7532.09% up from last year.
  • Neurocrine Biosciences' Consolidated Net Income amounted to $22.5 million in Q3 2021, which was up 13906.25% from $42.3 million recorded in Q2 2021.
  • Neurocrine Biosciences' Consolidated Net Income's 5-year high stood at $79.6 million during Q2 2020, with a 5-year trough of -$102.1 million in Q1 2019.
  • Moreover, its 5-year median value for Consolidated Net Income was $20.7 million (2018), whereas its average is $3.9 million.
  • As far as peak fluctuations go, Neurocrine Biosciences' Consolidated Net Income crashed by 29366.3% in 2017, and later skyrocketed by 96757.99% in 2019.
  • Over the past 5 years, Neurocrine Biosciences' Consolidated Net Income (Quarter) stood at $6.9 million in 2017, then skyrocketed by 172.82% to $18.8 million in 2018, then skyrocketed by 80.84% to $34.0 million in 2019, then tumbled by 269.35% to -$57.6 million in 2020, then surged by 139.06% to $22.5 million in 2021.
  • Its Consolidated Net Income stands at $22.5 million for Q3 2021, versus $42.3 million for Q2 2021 and $32.1 million for Q1 2021.